The estimated Net Worth of David I. Chemerow is at least $28.6 Thousand dollars as of 24 March 2022. Mr. Chemerow owns over 50,000 units of RiceBran Technologies stock worth over $28,637 and over the last 8 years he sold RIBT stock worth over $0. In addition, he makes $0 as Independent Director at RiceBran Technologies.
David has made over 5 trades of the RiceBran Technologies stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 50,000 units of RIBT stock worth $25,000 on 24 March 2022.
The largest trade he's ever made was buying 80,000 units of RiceBran Technologies stock on 19 December 2019 worth over $100,000. On average, David trades about 7,150 units every 89 days since 2016. As of 24 March 2022 he still owns at least 260,332 units of RiceBran Technologies stock.
You can see the complete history of Mr. Chemerow stock trades at the bottom of the page.
David I. Chemerow serves as Independent Director of the Company. He as served as a director since October 2018. From August 2016 to September 2017, Mr. Chemerow served as the chief financial officer and treasurer of Comscore, Inc., a digital data and analytics company, and from January 2016 to August 2016, Mr. Chemerow served as the chief revenue officer of Comscore, Inc. Mr. Chemerow served as the chief operating officer and chief financial officer of Rentrak Corporation, a media measurement and advanced consumer targeting company, from October 2009 until Rentrak Corporation was merged into comScore, Inc. in January 2016. Prior to 2009, Mr. Chemerow served in senior executive roles in several companies. Mr. Chemerow previously served as the non-executive chairman of the Board of Playboy Enterprises, Inc. and is a member of the board of directors of Dunham’s Athleisure Corporation, a sporting goods retailer. Mr. Chemerow serves on the board of The Martha’s Vineyard Playhouse, a non-profit theatre. Mr. Chemerow is a member and board leadership fellow of the National Association of Corporate Directors. Mr. Chemerow is a graduate of Dartmouth College and holds an MBA from The Amos Tuck School. The Board believes that Mr. Chemerow’s extensive experience, business knowledge and experience as CFO of several public companies are the attributes, skills, experiences and qualifications that allow Mr. Chemerow to make a valuable contribution as one of our directors.
David Chemerow is 68, he's been the Independent Director of RiceBran Technologies since 2018. There are no older and 6 younger executives at RiceBran Technologies.
David's mailing address filed with the SEC is C/O RICEBRAN TECHNOLOGIES #20, 25420 KUYKENDAHL ROAD, SUITE B300, TOMBALL, TX, 77375.
Over the last 12 years, insiders at RiceBran Technologies have traded over $4,078,827 worth of RiceBran Technologies stock and bought 7,837,541 units worth $14,259,016 . The most active insiders traders include Grain Co Continental, Brent D Rosenthal, and Brent Robert Rystrom. On average, RiceBran Technologies executives and independent directors trade stock every 33 days with the average trade being worth of $15,329. The most recent stock trade was executed by Grain Co Continental on 23 May 2022, trading 1,797,000 units of RIBT stock currently worth $1,293,840.
ricebran technologies (nasdaq: ribt) is unlocking the value of rice bran, an underutilized, renewable and sustainable by-product of the international rice milling industry. using our proprietary and patented technologies to stabilize and further process rice bran, we are able to produce nutrient dense, sustainably sourced rice bran ingredients that increase the nutritional value of foods and beverages. ricebran technologies’ products are non-gmo, vegetarian, vegan, and gluten free. our company has the potential to satisfy a significant portion of the increasing global demand for protein, dietary fiber, edible oil and other human food ingredients, as well as produce finished functional foods and rice bran based nutricosmetics. our technology captures the value of rice bran without increasing the use of arable land or water. ricebran technologies’ target markets include manufacturers and retailers for human food ingredients, packaged functional foods, nutraceuticals, personal care produc
RiceBran Technologies executives and other stock owners filed with the SEC include: